Basit öğe kaydını göster

dc.contributor.authorNarter, Kamil Fehmi
dc.contributor.authorErgen, Arzu
dc.contributor.authorIsbir, Turgay
dc.contributor.authorGormus, Uzay
dc.contributor.authorAgachan, Bedia
dc.contributor.authorTimirci, Ozlem
dc.date.accessioned2021-03-03T13:23:28Z
dc.date.available2021-03-03T13:23:28Z
dc.date.issued2009
dc.identifier.citationNarter K. F. , Ergen A., Agachan B., Gormus U., Timirci O., Isbir T., "Bladder Cancer and Polymorphisms of DNA Repair Genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1)", ANTICANCER RESEARCH, cilt.29, sa.4, ss.1389-1393, 2009
dc.identifier.issn0250-7005
dc.identifier.othervv_1032021
dc.identifier.otherav_33cab2a0-5d87-4e77-8923-a39ed4af52ec
dc.identifier.urihttp://hdl.handle.net/20.500.12627/39050
dc.description.abstractCarcinogenic molecules from cigarettes are known to cause DNA damage to bladder epithelial cells, but such damage can be corrected by some DNA repair mechanisms such as base and nucleotide excision repair, double-strand repair and mismatch repair. Various gene products play a role in these DNA repair systems. The aim of this study was to investigate six of these genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1) each of which has a separate role in these repair mechanisms. The study was performed on 83 bladder cancer patients and 45 health), controls. The genes were amplified by polymerase chain reaction (PCR) and restriction fragment polymorphism determinations were used to elucidate the specific changes in the gene region. There was no difference in smoking status between patient and control groups. It was found that there was a statistical significance in XRCC3 T carriers between patient and control groups and so there was a 4.87-fold protective role by the XRCC3 T allele against bladder cancer. The AA genotype and A allele carriers of the APE gene were more frequent in the transitional epithelial carcinoma group than in the adenocarcinoma group. The genotype distribution for the APE gene was determined to be significantly different between local and invasive cases; G allele carriers for this gene were significantly higher in invasive cancer types.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleBladder Cancer and Polymorphisms of DNA Repair Genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1)
dc.typeMakale
dc.relation.journalANTICANCER RESEARCH
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume29
dc.identifier.issue4
dc.identifier.startpage1389
dc.identifier.endpage1393
dc.contributor.firstauthorID69236


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster